190 related articles for article (PubMed ID: 21505075)
1. Peripheral nerve pathology, including aberrant Schwann cell differentiation, is ameliorated by doxycycline in a laminin-α2-deficient mouse model of congenital muscular dystrophy.
Homma S; Beermann ML; Miller JB
Hum Mol Genet; 2011 Jul; 20(13):2662-72. PubMed ID: 21505075
[TBL] [Abstract][Full Text] [Related]
2. Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy.
Girgenrath M; Beermann ML; Vishnudas VK; Homma S; Miller JB
Ann Neurol; 2009 Jan; 65(1):47-56. PubMed ID: 19086074
[TBL] [Abstract][Full Text] [Related]
3. A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination.
Patton BL; Wang B; Tarumi YS; Seburn KL; Burgess RW
J Cell Sci; 2008 May; 121(Pt 10):1593-604. PubMed ID: 18430779
[TBL] [Abstract][Full Text] [Related]
4. Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.
Rooney JE; Knapp JR; Hodges BL; Wuebbles RD; Burkin DJ
Am J Pathol; 2012 Apr; 180(4):1593-602. PubMed ID: 22322301
[TBL] [Abstract][Full Text] [Related]
5. The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy.
Hall TE; Bryson-Richardson RJ; Berger S; Jacoby AS; Cole NJ; Hollway GE; Berger J; Currie PD
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7092-7. PubMed ID: 17438294
[TBL] [Abstract][Full Text] [Related]
6. Ku70 regulates Bax-mediated pathogenesis in laminin-alpha2-deficient human muscle cells and mouse models of congenital muscular dystrophy.
Vishnudas VK; Miller JB
Hum Mol Genet; 2009 Dec; 18(23):4467-77. PubMed ID: 19692349
[TBL] [Abstract][Full Text] [Related]
7. The AChE membrane-binding tail PRiMA is down-regulated in muscle and nerve of mice with muscular dystrophy by merosin deficiency.
Vidal CJ; Montenegro MF; Muñoz-Delgado E; Campoy FJ; Cabezas-Herrera J; Moral-Naranjo MT
Chem Biol Interact; 2013 Mar; 203(1):330-4. PubMed ID: 22906800
[TBL] [Abstract][Full Text] [Related]
8. Laminin α1 reduces muscular dystrophy in dy
Gawlik KI; Harandi VM; Cheong RY; Petersén Å; Durbeej M
Matrix Biol; 2018 Sep; 70():36-49. PubMed ID: 29544677
[TBL] [Abstract][Full Text] [Related]
9. Schwann cell-specific ablation of laminin gamma1 causes apoptosis and prevents proliferation.
Yu WM; Feltri ML; Wrabetz L; Strickland S; Chen ZL
J Neurosci; 2005 May; 25(18):4463-72. PubMed ID: 15872093
[TBL] [Abstract][Full Text] [Related]
10. Schwann cell myelination occurred without basal lamina formation in laminin alpha2 chain-null mutant (dy3K/dy3K) mice.
Nakagawa M; Miyagoe-Suzuki Y; Ikezoe K; Miyata Y; Nonaka I; Harii K; Takeda S
Glia; 2001 Aug; 35(2):101-10. PubMed ID: 11460266
[TBL] [Abstract][Full Text] [Related]
11. Laminin alpha1 chain improves laminin alpha2 chain deficient peripheral neuropathy.
Gawlik KI; Li JY; Petersén A; Durbeej M
Hum Mol Genet; 2006 Sep; 15(18):2690-700. PubMed ID: 16893907
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Caspase Activation in Laminin-α2-Deficient Human Myogenic Cells is Mediated by p53 and Sirtuin Activity.
Yoon S; Beermann ML; Yu B; Shao D; Bachschmid M; Miller JB
J Neuromuscul Dis; 2018; 5(1):59-73. PubMed ID: 29278895
[TBL] [Abstract][Full Text] [Related]
13. Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A.
Doe JA; Wuebbles RD; Allred ET; Rooney JE; Elorza M; Burkin DJ
J Cell Sci; 2011 Jul; 124(Pt 13):2287-97. PubMed ID: 21652631
[TBL] [Abstract][Full Text] [Related]
14. TNFalpha mediates Schwann cell death by upregulating p75NTR expression without sustained activation of NFkappaB.
Boyle K; Azari MF; Cheema SS; Petratos S
Neurobiol Dis; 2005 Nov; 20(2):412-27. PubMed ID: 15905096
[TBL] [Abstract][Full Text] [Related]
15. Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies.
Yurchenco PD; McKee KK; Reinhard JR; Rüegg MA
Matrix Biol; 2018 Oct; 71-72():174-187. PubMed ID: 29191403
[TBL] [Abstract][Full Text] [Related]
16. Laminins in peripheral nerve development and muscular dystrophy.
Yu WM; Yu H; Chen ZL
Mol Neurobiol; 2007 Jun; 35(3):288-97. PubMed ID: 17917117
[TBL] [Abstract][Full Text] [Related]
17. Laminin gamma1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve.
Chen ZL; Strickland S
J Cell Biol; 2003 Nov; 163(4):889-99. PubMed ID: 14638863
[TBL] [Abstract][Full Text] [Related]
18. Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy.
Nguyen Q; Lim KRQ; Yokota T
Appl Clin Genet; 2019; 12():113-130. PubMed ID: 31308722
[TBL] [Abstract][Full Text] [Related]
19. Gpr126 is essential for peripheral nerve development and myelination in mammals.
Monk KR; Oshima K; Jörs S; Heller S; Talbot WS
Development; 2011 Jul; 138(13):2673-80. PubMed ID: 21613327
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of muscle and nerve pathology of Lama2-related dystrophy by AAV9-laminin-αLN linker protein.
McKee KK; Yurchenco PD
JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35639486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
